SE7613588L - Forfarande for framstellning av 3,4-dihydro-kinazolinderivat - Google Patents

Forfarande for framstellning av 3,4-dihydro-kinazolinderivat

Info

Publication number
SE7613588L
SE7613588L SE7613588A SE7613588A SE7613588L SE 7613588 L SE7613588 L SE 7613588L SE 7613588 A SE7613588 A SE 7613588A SE 7613588 A SE7613588 A SE 7613588A SE 7613588 L SE7613588 L SE 7613588L
Authority
SE
Sweden
Prior art keywords
dihydro
procedure
preparation
derivatives
chinazoline derivatives
Prior art date
Application number
SE7613588A
Other languages
English (en)
Inventor
G Doria
C Romeo
P Giraldi
F Lauria
M L Corno
P Sberze
M Tibolla
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of SE7613588L publication Critical patent/SE7613588L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/93—Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7613588A 1975-12-05 1976-12-03 Forfarande for framstellning av 3,4-dihydro-kinazolinderivat SE7613588L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT29998/75A IT1050750B (it) 1975-12-05 1975-12-05 Derivati della 3.4 di idro chinazolina

Publications (1)

Publication Number Publication Date
SE7613588L true SE7613588L (sv) 1977-06-06

Family

ID=11228830

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7613588A SE7613588L (sv) 1975-12-05 1976-12-03 Forfarande for framstellning av 3,4-dihydro-kinazolinderivat

Country Status (22)

Country Link
US (1) US4251531A (sv)
JP (1) JPS5271485A (sv)
AT (1) AT355029B (sv)
AU (1) AU505660B2 (sv)
BE (1) BE848696A (sv)
CA (1) CA1084051A (sv)
CH (2) CH626073A5 (sv)
CS (1) CS194786B2 (sv)
DE (1) DE2654215A1 (sv)
DK (1) DK147855C (sv)
FI (1) FI64359C (sv)
FR (1) FR2333511A1 (sv)
GB (1) GB1523081A (sv)
HU (1) HU177817B (sv)
IL (1) IL50849A (sv)
IT (1) IT1050750B (sv)
NL (1) NL7613450A (sv)
NO (1) NO146095C (sv)
NZ (1) NZ182778A (sv)
SE (1) SE7613588L (sv)
SU (1) SU786894A3 (sv)
ZA (1) ZA766745B (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69274A (en) * 1982-08-05 1986-08-31 Erba Farmitalia (substituted amino)derivatives of 3-benzylidene-pyrrolo(2,1-b)quinazolin-9-ones and 6-benzylidene-pyrido(2,1-b)quinazolin-11-ones,their preparation and pharmaceutical compositions containing them
JPS5925224U (ja) * 1982-08-10 1984-02-16 株式会社根来 かばん
US4666913A (en) * 1985-11-22 1987-05-19 William H. Rorer, Inc. Hydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their uses
GB8827988D0 (en) * 1988-11-30 1989-01-05 Smith Kline French Lab Chemical compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
DE69934113T2 (de) * 1998-05-22 2007-06-06 Abbott Laboratories, Abbott Park Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen
US6632961B1 (en) * 1998-05-22 2003-10-14 Abbott Laboratories Antiangiogenic drug to treat cancer, arthritis and retinopathy
CO5170498A1 (es) * 1999-05-28 2002-06-27 Abbott Lab Biaril sulfonamidas son utiles como inhibidores de proliferacion celular
AU2002257195A1 (en) * 2001-04-23 2002-11-05 University Of Virginia Patent Foundation Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
DE602004025803D1 (de) * 2003-06-06 2010-04-15 Arexis Ab Verwendung von kondensierten heterozyklischen verbindungen als scce-hemmern zur behandlung von hautzuständen
CN100518740C (zh) * 2003-06-06 2009-07-29 阿里克斯股份公司 杂环化合物作为scce抑制剂的制药用途
KR101419075B1 (ko) * 2006-08-08 2014-07-11 아스카 세이야쿠 가부시키가이샤 퀴나졸린 유도체
US8053440B2 (en) 2007-02-01 2011-11-08 Resverlogix Corporation Compounds for the prevention and treatment of cardiovascular diseases
BRPI1009315B8 (pt) 2009-03-18 2021-05-25 Resverlogix Corp composto anti-flamatórios e suas composições farmacêuticas
TR201818390T4 (tr) 2009-04-22 2019-01-21 Resverlogix Corp Yeni̇ anti̇-i̇nflamatuvar ajanlar
US10111885B2 (en) 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
GB201510254D0 (en) * 2015-06-12 2015-07-29 Syngenta Participations Ag Improvements in or relating to organic compounds
JP7427252B2 (ja) * 2018-06-27 2024-02-05 株式会社リボルナバイオサイエンス 脊髄性筋萎縮症の予防または治療剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3696102A (en) * 1970-03-09 1972-10-03 Pfizer & Co C Process for the synthesis of substituted quinazolin-4-ones

Also Published As

Publication number Publication date
FI64359B (fi) 1983-07-29
JPS5543464B2 (sv) 1980-11-06
GB1523081A (en) 1978-08-31
AU1947276A (en) 1978-05-18
FR2333511B1 (sv) 1979-03-02
CS194786B2 (en) 1979-12-31
NO146095B (no) 1982-04-19
FI64359C (fi) 1983-11-10
CH626073A5 (sv) 1981-10-30
DK546776A (da) 1977-06-06
IT1050750B (it) 1981-03-20
CH626075A5 (sv) 1981-10-30
FI763391A (sv) 1977-06-06
AT355029B (de) 1980-02-11
JPS5271485A (en) 1977-06-14
DK147855C (da) 1985-06-10
HU177817B (en) 1981-12-28
FR2333511A1 (fr) 1977-07-01
IL50849A (en) 1980-11-30
DK147855B (da) 1984-12-24
ATA894376A (de) 1979-07-15
DE2654215A1 (de) 1977-06-16
AU505660B2 (en) 1979-11-29
US4251531A (en) 1981-02-17
NO764135L (sv) 1977-06-07
ZA766745B (en) 1977-10-26
CA1084051A (en) 1980-08-19
IL50849A0 (en) 1977-01-31
SU786894A3 (ru) 1980-12-07
BE848696A (fr) 1977-03-16
NO146095C (no) 1982-08-11
NZ182778A (en) 1978-07-28
NL7613450A (nl) 1977-06-07

Similar Documents

Publication Publication Date Title
SE7613588L (sv) Forfarande for framstellning av 3,4-dihydro-kinazolinderivat
NO155885C (no) Analogifremgangsmaate for fremstilling av tiazolderivater med anti-ulcus-egenskaper.
RO68460A (ro) Procedeu pentru prepararea unor derivati de azetidinona
IT1057250B (it) Derivati del 6..7 benzomorfano e procedimento per la loro preparazione
SE434946B (sv) Forfarande for framstellning av acylsackariner och acyl-3-oxo-1,2-densisotiazoliner
SE7603791L (sv) Forfarande for framstellning av 17 alfa-ester-21-halogenpregnaner
MX3743E (es) Procedimiento para la preparacion de derivados 3,4-dihidro-2 (lh)-quinazolinona
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
PT66089B (en) Process for preparing 1,2-benzisothiazolin-3-ona with anti-thrombotic effect application of same for the preparationof pharmaceutical compositions with anti-thrombic effect and application of these pharmaceutical compositions for the treatment of thrombosis
AR204390A1 (es) Procedimiento de preparacion de derivados de imidazolidinonas y perhidropirimidinonas n,n' bisustituidas
SE409703B (sv) Forfarande for framstellning av cykliska undekapeptidanaloger av somatostatin
SE433353B (sv) Analogiforfarande for framstellning av pyrido/1,2-a/pyrimidiner med antiflogistisk och koagulationshemmande verkan
BE854485R (fr) Composition empechant une croissance de l'encrassement
IT8021795A0 (it) Derivati del 5h-furanone-2 e del3h-diidrofuranone-2,loro procedimento di preparazione e loro applicazione terapeutica.
SE435290B (sv) Forfarande for framstellning av gamma-kristallin form av natrium-7-(d-alfa-formyloxi-alfa-fenylacetamido)-(2-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylat
SE7605940L (sv) Forfarande for framstellning av homo- och sampolymerisat av tetrafluoreten
SE407937B (sv) Forfarande for framstellning av 1,3,4-substituerade 2-pyrrolidoner med terapentiska egenskaper
BE846956A (fr) Derives de 1-carbamoyl-k-fluorouracile et leur utilisation comme agents antineoplasiques,
AR215851A1 (es) Procedimiento para la preparacion de 12,13-desepoxi-12,13-dehidrorosaramicina y derivados de la misma
IT1039349B (it) Metodo per la preparazione del 2 idrossibenzantrone e dei suoi derivati di sostituzione
SE7808138L (sv) Pyranokromonderivat och terapeutisk komposition innehallande detsamma for behandling av allergiska sjukdomar
SE380527B (sv) Forfarande for framstellning av 1oh-tieno(3,2-c)(1)-bensazepinderivat
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
NO142444C (no) Fremgangsmaate for fremstilling av foretrede melamin-formaldehydharpikser i vandig opploesning
SE7713587L (sv) Forfarande for framstellning av oxazolidindionderivat av vinkaalkaloider

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7613588-8